Sep 20,2022

CytoReason Raises $20 Million From Pfizer

Cytoreason, an Israeli medtech startup, raised $20 million from Pfizer in an extension of its multi-year partnership with that company to use CytoReason�s artificial intelligence technology for Pfizer�s drug development programs. The new funds will be an equity investment and Pfizer will have options to license CytoReason�s platform and disease models, and?fund?supplementary project support, in a deal potentially worth up to $110M over the next five years. The new research agreement and investment will support the development of additional disease models and the creation of high-resolution models, spanning across a number of therapeutic areas.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Sep 27,2022

Oxford-based Optellum raises $14m in funding round

Optellum, an Oxford-based medtech company that provides an AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round. The investment will allow the company to scale its base, operations and commercial launches in the UK and USA, accelerate its research and development, and expand its platform into personalised therapy decisions, integrating imaging with molecular data, robotics, and liquid biopsies. This funding round was led by Mercia, with additional investors Intuitive Ventures and Black Opal Ventures. Existing investors including St John�s College in the University of Oxford, IQ Capital, and the family office of Sir Martin & Lady Audrey Wood also participated in this round.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Oct 20,2022

Tempus Announces $100 Million in Funding

Tempus, a leader in artificial intelligence and precision medicine, today announced additional funding of approximately $275 million through a combination of equity from existing investors, which Tempus sold at the same price per share as its previous fundraising round, and debt financing from funds managed by Ares Management. In total, Tempus has now raised over $1.3 billion.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Oct 20,2022

Tempus Announces $175 Million in Debt Financing

Biotech upstart Tempus announced on Thursday it raised $275 million through equity from previous investors and debt financing from Ares Management.

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
Feb 15,2023

Macmillan invests in Neutrocheck device for home-testing neutropenic sepsis

Macmillan Cancer Support, the cancer charity, has invested in Neutrocheck – a portable device and accompanying app in development from 52 North Health – with the aim to help people with cancer test their risk of life-threatening neutropenic sepsis at home rather than at hospital. Macmillan’s £100,000 investment in Neutrocheck is the first for the charity’s new Innovation Impact Investment Portfolio. By investing in this way, Macmillan hopes to play a critical role in developing new ways to transform the lives of people with cancer, and inspire other organisations and investors to support innovation in cancer care. 

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Jan 10,2014

WellDoc raises $20 million from Merck GHI Fund, Windham

Baltimore, Maryland-based WellDoc, one of the earliest and best known mobile health companies focused on diabetes management, has landed a $20 million round of investment that includes contributions from Merck Global Health Innovation Fund and Windham Venture Partners. The announcement marks WellDoc's first round of institutional money -- the company has long relied on angel investors and debt -- and now reports total funding at north of $50 million.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Feb 26,2014

mySugr raises a few million euros for diabetes app

Diabetes app maker mySugr, which is based in Austria and the US, raised a few million euros in an investment round led by XL Health and Puspok. Johann Hansmann, an angel investor that has previously invested in Runtastic, also participated. mySugr had previously raised another round from Hansmann and Austria's state owned investment bank, AWS. One of mySugr's investors, XL Health is a subsidiary of EHR maker CompuGroup Medical, which the company expects will help it become better integrated into healthcare systems.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Mar 19,2014

AbleTo raises $1.5M

The document is a Form D filing submitted to the US Securities and Exchange Commission by AbleTo, a provider of behavioral health solutions. According to the filing, AbleTo has raised $6,000,005 USD through the issuance of equity securities to an undisclosed group of investors. The funds raised will be used for working capital and general corporate purposes.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Apr 28,2014

Voluntis Raises € 20.75 Million ($ 29 Million)

Voluntis, a company pioneering therapeutic companion software, today announced the completion of its Series D financing round. With a total of €20.75 million ($29 million), this fund raising is one of the largest rounds of investment in the m-health sector this year. The round was co-led by Bpifrance Large Venture and international venture capital firm Innovation Capital. Luxemburg-based Vesalius Biocapital and US-based Qualcomm Incorporated, through its venture capital arm, Qualcomm Ventures, contributed to the round. Voluntis existing Series C investors, CapDecisif Management, CM-CIC Capital Innovation and Sham, also participated in the round.

FUNDING SERIES D
View Analyst & Ambassador Comments
Go to original news
Apr 28,2014

London-based medtech startup Big Health raises $3.3m

Big Health, a London-based medtech startup, has secured 3.3 million in a Series A funding round led by Forward Partners and Index Ventures. The young company plans to use the fresh capital to support its upcoming US expansion.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING